ARCHIVES

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

This article is from The Cancer Letter archive.

Vol. 18 No. 41 | October 23, 1992

Download PDF Visit The Full Archive

Related Articles

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

Young Scientists Get Their Share Of NCI Grants

March 29, 1974

In Congress: HHS Hasn’t Identified Another Source For NIH Increase If Tobacco Bill Not Passed: Shalala

March 6, 1998

In Brief: GM Awards Recognize Levine, Levy, Roeder, Tjian; U.S. Science, Tech Medals Awarded

May 14, 1999

Evansvile CCOP Withdrawn, Cites Budget Cut, DR

September 9, 1983

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005